Sally is responsible for delineating the company’s strategy and realizing operational excellence. In collaboration with the executive leadership team, she oversees the development and implementation of organizational goals and business strategies.

With over 22 years of commercial and operational experience in drug development and regulatory science, Sally spearheads our strategy to drive growth and ensure client engagement through our industry-leading PV services and solutions. Previously, as Head of the Regulatory Affairs and Clinical Delivery at Ergomed, she successfully integrated the regulatory function within PrimeVigilance, which include our vast PV Network and regulatory intelligence analytics.

Prior to joining Ergomed, Sally held leadership positions at WCT, PPD and Syneos, as well as Biogen, Pfizer and GSK, where she led successful turnarounds and transformational campaigns, re-designed and expanded service capabilities, and provided executive leadership on numerous company-wide initiatives with remarkable returns on investment.

Sally is a staunch advocate of transparency, quality and continuous improvement.

Sally holds a Master’s degree in Biotechnological Law and Ethics from the University of Sheffield which preceded her MBA from the University of Liverpool, in the UK.